10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001185185-12-000341 |
| Period End Date | 20111231 |
| Filing Date | 20120308 |
| Fiscal Year | 2011 |
| Fiscal Period | FY |
| XBRL Instance | unxl-20111231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
43 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accumulated depreciation (in Dollars) |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.54M | USD | Point-in-time |
| Accumulated depreciation (in Dollars) |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.98M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$307.85K | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$77.89K | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$4.55K | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
7.13M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$13.13M | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
7.14M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$7.22M | USD | Point-in-time |
| Property and equipment, net of accumulated depreciation of $1,977,241 and $1,543,839, at December 31, 2011 and 2010, respectively |
PropertyPlantAndEquipmentNet
|
$70.73K | USD | Point-in-time |
| Property and equipment, net of accumulated depreciation of $1,977,241 and $1,543,839, at December 31, 2011 and 2010, respectively |
PropertyPlantAndEquipmentNet
|
$1.15M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
7.13M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
7.14M | shares | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$17.44K | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalentsAtCarryingValue
|
$17.44K | USD | Point-in-time |
| Total assets |
Assets
|
$13.22M | USD | Point-in-time |
| Total assets |
Assets
|
$8.39M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$341.54K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$87.47K | USD | Point-in-time |
| Deferred revenue |
DeferredRevenueCurrent
|
$85.91K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$87.47K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$427.45K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$87.47K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$427.45K | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares and 7,131,890 shares issued and outstanding at December 31, 2011 and 2010, respectively |
CommonStockValue
|
$7.14K | USD | Point-in-time |
| Common stock, $0.001 par value; 100,000,000 shares authorized, 7,142,307 shares and 7,131,890 shares issued and outstanding at December 31, 2011 and 2010, respectively |
CommonStockValue
|
$7.13K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$70.59M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$66.51M | USD | Point-in-time |
| Accumulated deficit during development stage |
RetainedEarningsAccumulatedDeficit
|
$-53.73M | USD | Point-in-time |
| Accumulated deficit during development stage |
RetainedEarningsAccumulatedDeficit
|
$-62.30M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquity
|
$-2.13M | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$8.39M | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$13.22M | USD | Point-in-time |
Income Statement
26 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue |
SalesRevenueNet
|
$243.52K | USD | Annual |
| Revenue |
SalesRevenueNet
|
$195.24K | USD | Annual |
| Cost of revenues |
CostOfRevenue
|
$46.98K | USD | Annual |
| Cost of revenues |
CostOfRevenue
|
$20.70K | USD | Annual |
| Gross margin |
GrossProfit
|
$148.25K | USD | Annual |
| Gross margin |
GrossProfit
|
$222.82K | USD | Annual |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$2.75M | USD | Annual |
| Selling, general and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$4.19M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$2.55M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$4.54M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-8.58M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-5.08M | USD | Annual |
| Gain on sale of intellectual property |
GainLossOnDispositionOfIntangibleAssets
|
$2.09M | USD | Annual |
| Debt issuance expense |
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
$554.83K | USD | Annual |
| Interest income (expense), net |
InterestExpense
|
$274.70K | USD | Annual |
| Interest income (expense), net |
InterestExpense
|
$-11.99K | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-3.82M | USD | Annual |
| Net loss - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-1.05 | USD | Annual |
| Net loss - basic (in Dollars per share) |
EarningsPerShareBasic
|
$-1.20 | USD | Annual |
| Net loss - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-1.20 | USD | Annual |
| Net loss - diluted (in Dollars per share) |
EarningsPerShareDiluted
|
$-1.05 | USD | Annual |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
3.63M | shares | Annual |
| Weighted average number of basic common shares outstanding (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
7.14M | shares | Annual |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
7.14M | shares | Annual |
| Weighted average number of diluted common shares outstanding (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
3.63M | shares | Annual |
Cash Flow Statement
46 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-3.82M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$433.40K | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$222.26K | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$2.35M | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$4.01M | USD | Annual |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$554.83K | USD | Annual |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$33.77K | USD | Annual |
| Amortization of discounts on notes payable |
AmortizationOfDebtDiscountPremium
|
$53.82K | USD | Annual |
| Gain on sale of intellectual property |
GainLossOnDispositionOfIntangibleAssets
|
$2.09M | USD | Annual |
| Decrease in cash restricted for lease obligations |
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
$17.44K | USD | Annual |
| (Increase) decrease in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$39.56K | USD | Annual |
| (Increase) decrease in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-77.89K | USD | Annual |
| Decrease in prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$3.40K | USD | Annual |
| Decrease in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-254.07K | USD | Annual |
| Decrease in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-586.10K | USD | Annual |
| Decrease in accrued interest payable |
IncreaseDecreaseInInterestPayableNet
|
$-61.32K | USD | Annual |
| Increase (decrease) in deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$-85.91K | USD | Annual |
| Increase (decrease) in deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$52.57K | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-3.38M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.39M | USD | Annual |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$8.55K | USD | Annual |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$1.51M | USD | Annual |
| Proceeds from the sale of intellectual property |
ProceedsFromSaleOfIntangibleAssets
|
$2.25M | USD | Annual |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$2.24M | USD | Annual |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.51M | USD | Annual |
| Proceeds from convertible notes payable |
ProceedsFromConvertibleDebt
|
$775.00K | USD | Annual |
| Payments on convertible notes payable |
RepaymentsOfConvertibleDebt
|
$2.06M | USD | Annual |
| Payments of deferred loan costs |
PaymentsOfDebtIssuanceCosts
|
$108.73K | USD | Annual |
| Proceeds from exercise of stock options, net |
ProceedsFromStockOptionsExercised
|
$73.14K | USD | Annual |
| Proceeds from the issuance of common stock, net |
ProceedsFromIssuanceOfCommonStock
|
$15.28M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$73.14K | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$13.88M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-5.83M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$12.74M | USD | Annual |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$307.85K | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$13.05M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$7.22M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$307.85K | USD | Point-in-time |
| Cash paid for interest |
InterestPaid
|
$196.04K | USD | Annual |
| Issuance of warrants to convertible note investors |
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
|
$12.01K | USD | Annual |
| Issuance of warrants to Placement Agent |
IssuanceOfStockAndWarrantsForServicesOrClaims
|
$60.55K | USD | Annual |
| Issuance of warrants to underwriter |
IssuanceOfWarrantsToUnderwriter
|
$1.53M | USD | Annual |
| Exchange of debt and accrued interest into common stock |
DebtConversionConvertedInstrumentAmount1
|
$1.04M | USD | Annual |
Stockholders Equity
15 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-2.13M | USD | Point-in-time |
| Issuance of common stock, net of issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$15.28M | USD | Annual |
| Conversion of debt and accrued interest into common stock |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
$1.04M | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$2.35M | USD | Annual |
| Stock compensation expense |
ShareBasedCompensation
|
$4.01M | USD | Annual |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$73.14K | USD | Annual |
| Issuance of warrants to convertible note investors |
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
|
$12.01K | USD | Annual |
| Issuance of warrants to placement agent |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$60.55K | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-8.57M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-3.82M | USD | Annual |
| Balance |
StockholdersEquity
|
$12.79M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$8.30M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$-2.13M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.